ArticleThe Lancet. Infectious diseases2023

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.

Betty Mwesigwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.